BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 24793443)

  • 1. An assessment by the Statin Muscle Safety Task Force: 2014 update.
    Rosenson RS; Baker SK; Jacobson TA; Kopecky SL; Parker BA; The National Lipid Association's Muscle Safety Expert Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S58-71. PubMed ID: 24793443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of statin safety by muscle experts.
    Thompson PD; Clarkson PM; Rosenson RS;
    Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment by the Statin Intolerance Panel: 2014 update.
    Guyton JR; Bays HE; Grundy SM; Jacobson TA; The National Lipid Association Statin Intolerance Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S72-81. PubMed ID: 24793444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of vitamin D deficiency to statin myopathy.
    Gupta A; Thompson PD
    Atherosclerosis; 2011 Mar; 215(1):23-9. PubMed ID: 21185021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.
    Jacobson TA
    Mayo Clin Proc; 2008 Jun; 83(6):687-700. PubMed ID: 18533086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment by the Statin Cognitive Safety Task Force: 2014 update.
    Rojas-Fernandez CH; Goldstein LB; Levey AI; Taylor BA; Bittner V; The National Lipid Association's Safety Task Force
    J Clin Lipidol; 2014; 8(3 Suppl):S5-16. PubMed ID: 24793442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STOMPing forward: statins, muscle complaints and CK.
    Laaksonen R
    Atherosclerosis; 2013 Oct; 230(2):256-7. PubMed ID: 24075753
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin-associated myopathy and its exacerbation with exercise.
    Meador BM; Huey KA
    Muscle Nerve; 2010 Oct; 42(4):469-79. PubMed ID: 20878737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.
    Glueck CJ; Budhani SB; Masineni SS; Abuchaibe C; Khan N; Wang P; Goldenberg N
    Curr Med Res Opin; 2011 Sep; 27(9):1683-90. PubMed ID: 21728907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced myalgia may limit the cardiovascular benefits of statins.
    Opie LH
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):569-72. PubMed ID: 23934075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presymptomatic neuromuscular disorders disclosed following statin treatment.
    Tsivgoulis G; Spengos K; Karandreas N; Panas M; Kladi A; Manta P
    Arch Intern Med; 2006 Jul; 166(14):1519-24. PubMed ID: 16864763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment by the Statin Liver Safety Task Force: 2014 update.
    Bays H; Cohen DE; Chalasani N; Harrison SA; The National Lipid Association's Statin Safety Task Force
    J Clin Lipidol; 2014; 8(3 Suppl):S47-57. PubMed ID: 24793441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
    Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
    J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLA Task Force on Statin Safety--2014 update.
    Jacobson TA
    J Clin Lipidol; 2014; 8(3 Suppl):S1-4. PubMed ID: 24793438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.